Form 8-K - Current report:
SEC Accession No. 0001193125-09-116899
Filing Date
2009-05-22
Accepted
2009-05-21 21:06:25
Documents
1
Period of Report
2009-05-19
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 13965
  Complete submission text file 0001193125-09-116899.txt   15809
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 09846709
SIC: 2835 In Vitro & In Vivo Diagnostic Substances